Smith I E, Peckham M J, McElwain T J, Gazet J C, Austin D E
Br J Cancer. 1977 Jul;36(1):120-9. doi: 10.1038/bjc.1977.162.
Fifty-nine children with Hodgkin's disease were seen over a 34-year period. Compared with Hodgkin's disease in adults, there was an increased male incidence, especially in the younger children. This was associated with an increased male incidence of lymphocyte-predominant histology. Forty-six patients underwent lymphography as part of their staging, and 13 had staging laparotomies. The 5-year survival for the entire group was 85%, with a median survival of 10 years. Response to radiotherapy in children with Stages I-IIIA disease was: 12 children treated with involved-field radiotherapy after inadequate clinical staging had a 3-year remission rate of 13%, and a median length of remission of 18 months; 24 children treated with extended-field radiotherapy after adequate clinical staging, including lymphography, had a 3-year remission rate of 72%, and a median duration of remission not yet reached; 3 children treated with elective local radiotherapy for Stage IA disease after intensive clinical staging remain in complete remission for periods of up to 34 months. Eight out of 10 children with Stages IIIB-IV disease, treated with combination chemotherapy, achieved complete remission with a 3-year remission rate of 70%; 7 children treated with combination chemotherapy following relapse after radiotherapy all achieved complete remission with a 3-year complete remission rate of 66%. Thirteen children underwent laparotomy and splenectomy as a staging procedure. Five were found to have intra-abdominal disease, including 4 with splenic involvement. These results show that there is no place for involved-field radiotherapy after inadequate clinical staging, in the management of childhood Hodgkin's disease. Extended-field radiotherapy after adequate staging, and combination chemotherapy, produce results which are as good as those for adults, but the benefits of these treatments and of staging laparotomy must be balanced against the possible complications when they are used in children. These problems are discussed and a scheme of management is proposed.
在34年期间诊治了59例霍奇金病患儿。与成人霍奇金病相比,男性发病率增加,尤其是年幼儿童。这与淋巴细胞为主型组织学的男性发病率增加有关。46例患者接受了淋巴造影作为其分期的一部分,13例进行了分期剖腹探查术。整个组的5年生存率为85%,中位生存期为10年。I-IIIA期疾病患儿对放疗的反应如下:12例在临床分期不充分后接受累及野放疗的患儿,3年缓解率为13%,中位缓解期为18个月;24例在包括淋巴造影在内的充分临床分期后接受扩大野放疗的患儿,3年缓解率为72%,中位缓解期尚未达到;3例在强化临床分期后因IA期疾病接受选择性局部放疗的患儿,完全缓解期长达34个月。10例IIIB-IV期疾病患儿中,8例接受联合化疗,完全缓解,3年缓解率为70%;7例放疗后复发接受联合化疗的患儿均完全缓解,3年完全缓解率为66%。13例患儿接受剖腹探查和脾切除术作为分期手术。5例发现有腹腔内疾病,包括4例脾受累。这些结果表明,在儿童霍奇金病的治疗中,临床分期不充分后进行累及野放疗没有意义。充分分期后进行扩大野放疗和联合化疗,其效果与成人相似,但在儿童中使用这些治疗方法和分期剖腹探查术时,必须权衡其益处与可能的并发症。对这些问题进行了讨论并提出了一个治疗方案。